In strengthening Canada’s health care, we must maintain employer-sponsored drug plans

Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for employers, unions, and families.

Rather than a complete overhaul of the current system that already provides millions of Canadians with comprehensive coverage, Canada can create a safety net that would extend essential coverage to those who are uninsured or underinsured, and those ineligible for other public insurance programs, ensuring that no Canadian falls through the cracks. Photograph courtesy of jarmoluk/Pixabay

Opinion

BY CAROLYNE EAGAN

February 21, 2024

OTTAWA—As the deadline nears for the Liberal government to unveil a national pharmacare framework that the NDP will support, the question of how to ensure equitable access to essential medications remains at the forefront of any discussion on health care in Canada. As we n...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy